On Feb 24, the third Healthy China Development Conference took place in Taizhou Medical High Tech Zone, with the theme being industrial cooperation and healthy China.
COVID-19 vaccine producer Jiangsu Recbio Technology Co Ltd broke ground on a vaccine expansion project with an investment of 1.08 billion yuan ($158.66 million) on Feb 6.
In the wake of the Spring Festival holiday, businesses resident in the Taizhou Medical High-tech Zone have restarted operations at a brisk pace, to ensure strong financial results in the first quarter.
During the Chinese Spring Festival holiday, investment and production work was still underway in the Chemicals New Materials Industry Park – located in the Taizhou Medical High-tech Zone, in Taizhou city, in East China's Jiangsu province.
The Taizhou Medical High-tech Zone – also known as China Medical City, located in Taizhou city, in East China's Jiangsu province – is poised to boost the high-quality development of its big health industry.
Founded in 1971, the Yangtze River Pharmaceutical Group, or YRPG, is a Chinese pharmaceutical group listed by the Ministry of Science and Technology as one of the first Innovative Enterprises of China.
